Please assess the completion status of the following clinical trial:

Trial Title: To Determine the Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Nigeria

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria: The patients should be aged 30-59 years with a sitting SBP ≥140 mm Hg and \<160 mmHg and/or DBP ≥ 90 and \<100 mmHg on no antihypertensive agent~Exclusion Criteria:~1.Those with clinically defined congestive heart failure 2. Those with clinical features of renal failure 3. Those with history of coronary heart disease including chronic stable angina, myocardial infarction or acute coronary syndrome 4. Patients with a history of a stroke or transient ischaemic attack 5. Patients with known or suspected secondary hypertension 6. Those with any other concomitant illness, physical or mental impairment that could interfere with the effective conduct of the study 7. Those who are pregnant or those of child-bearing age who are not taking reliable contraception.~-

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 59 Years
- Healthy Volunteers: f

Study Arms:
- Hypertensives to receiving Nevibolol (Type: None): Patients to receive Nevibolol

Based on this trial design, predict the completion outcome and termination type (if applicable).